IP Library Assignment 075803/0558
Patent Assignment
Reel/Frame 075803/0558

Amended and Restated Patent Security Agreement

Recorded: 2026-06-04 Pages: 18
Assignors
VALNEVA AUSTRIA GMBH
Executed: 2026-06-03
VALNEVA SE
Executed: 2026-06-03
VALNEVA SWEDEN AB
Executed: 2026-06-03
Assignee
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
C/O MUFG CORPORATE GOVERNANCE LIMITED, 51 LIME STREET, 19TH FLOOR, LONDON, EC3M 7DQ, UNITED KINGDOM
Covered Properties (63)
Virus Purification
Application: 16/062,245 →
Publication: US US20180369359A1
Virus Purification
Application: 16/702,764 →
Publication: US US20200197506A1
Aluminum Compounds for Use in Therapeutics and Vaccines
Patent: 9,913,898 →
Application: 15/223,027 →
Publication: US US20160324959A1
Aseptic Purification Process for Viruses
Application: 15/561,094 →
Publication: US US20180119110A1
Aseptic Purification Process for Viruses
Application: 16/815,215 →
Publication: US US20200347364A1
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Patent: 9,598,472 →
Application: 14/342,565 →
Publication: US US20150056238A1
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Application: 15/421,808 →
Publication: US US20170239340A1
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Application: 16/295,031 →
Publication: US US20190290747A1
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Application: 17/061,891 →
Publication: US US20210121554A1
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Application: 17/406,765 →
Publication: US US20210393761A1
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Application: 17/930,742 →
Publication: US US20230173052A1
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Application: 19/202,001 →
Publication: US US20250360191A1
Chikungunya Vaccine Formulations
Application: 17/632,943 →
Publication: US US20220288185A1
Clostridium Difficile Vaccine
Application: 18/867,201 →
Publication: US US20250213667A1
CpG-ADJUVANTED SARS-CoV-2 VIRUS VACCINE
Application: 17/471,904 →
Publication: US US20230038284A1
Cholera Vaccine Formulation
Application: 18/027,657 →
Publication: US US20230372464A1
Method of Making a Virus Using Duck Embryonic Derived Stem Cell Lines
Patent: 9,822,345 →
Application: 15/013,079 →
Publication: US US20160257940A1
Compositions Comprising Three Ospa Fusion Proteins for Medical Use
Application: 17/917,624 →
Publication: US US20230173051A1
Immunogenic Chikungunya Compositions for Administration to Immunocompromised Patients
Application: 19/162,120 →
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Application: 16/641,012 →
Publication: US US20210322534A1
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NP3
Application: 17/407,499 →
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Application: 17/935,490 →
Publication: US US20230293661A1
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Application: 18/655,777 →
Publication: US US20250073326A1
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Application: 19/449,736 →
Publication: US US20260240977A1
Aluminum Compounds for Use in Therapeutics and Vaccines
Patent: 9,884,115 →
Application: 14/873,344 →
Publication: US US20160114033A1
Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
Application: 15/469,689 →
Publication: US US20170296656A1
Aluminum Compounds for Use in Therapeutics and Vaccines
Application: 16/734,866 →
Publication: US US20200360511A1
Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
Application: 17/393,888 →
Publication: US US20220125917A1
Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
Application: 19/411,478 →
Publication: US US20260199456A1
Aluminum Compounds for Use in Therapeutics and Vaccines
Patent: 9,895,437 →
Application: 13/449,596 →
Publication: US US20130280295A1
Improvements in Vaccine Formulations for Medical Use
Application: 17/917,010 →
Publication: US US20230398210A1
Zika Virus Vaccine
Application: 16/063,007 →
Publication: US US20200017555A9
Zika Virus Vaccine
Application: 16/813,862 →
Publication: US US20200384099A1
Zika Virus Vaccine
Application: 17/548,721 →
Publication: US US20220273786A1
Zika Virus Vaccine
Application: 18/178,638 →
Publication: US US20230226165A1
Zika Virus Vaccine
Application: 18/334,497 →
Publication: US US20240108712A1
Zika Virus Vaccine
Application: 18/799,291 →
Publication: US US20250018023A1
Inactivation Process for Viruses
Application: 17/688,960 →
Publication: US US20220298493A1
Improved Methods of Producing a Lipidated Protein
Application: 17/917,016 →
Publication: US US20240026412A1
Method for Rescuing and Producing a Virus in Avian Cells
Application: 17/260,054 →
Publication: US US20210275662A1
A Method of Obtaining Chicken Embryonic Stem Cells
Patent: 8,962,311 →
Application: 12/376,660 →
Publication: US US20100235937A1
Multivalent Ospa Polypeptides and Methods and Uses Relating Thereto
Application: 16/497,178 →
Publication: US US20230151063A1
Multivalent Ospa Polypeptides and Methods and Uses Relating Thereto
Application: 18/665,018 →
Publication: US US20250101069A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Patent: 9,975,927 →
Application: 15/110,151 →
Publication: US US20160333056A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application: 15/944,835 →
Publication: US US20180362593A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application: 16/990,023 →
Publication: US US20210054032A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application: 19/386,871 →
Publication: US US20260070950A1
MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO
Patent: 8,986,704 →
Application: 13/802,991 →
Publication: US US20140010835A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Patent: 9,926,343 →
Application: 15/267,372 →
Publication: US US20170107263A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application: 15/272,581 →
Publication: US US20170101446A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application: 15/906,618 →
Publication: US US20180327460A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application: 16/702,885 →
Publication: US US20200239525A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application: 17/517,477 →
Publication: US US20220185851A1
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application: 17/932,226 →
Publication: US US20230295245A1
Process for Virus Production in a Bioreactor
Application: 19/147,841 →
Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines
Patent: 8,148,132 →
Application: 11/918,206 →
Publication: US US20090081251A1
Single Shot Chikungunya Virus Vaccine
Application: 17/632,946 →
Publication: US US20220313810A1
Virus Purification
Application: 15/781,959 →
Publication: US US20180362937A1
Virus Purification
Application: 16/840,760 →
Publication: US US20200368342A1
Virus Purification
Application: 17/811,059 →
Publication: US US20230056142A1
Zika Virus Purification
Application: 15/781,825 →
Publication: US US20180362936A1
Zika Virus Purification
Application: 16/927,086 →
Publication: US US20210093707A1
Zika Virus Purification
Application: 16/060,054 →
Publication: US US20190008945A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 30, 2014
From: WESTRITSCHNIG, KERSTIN
To: VALNEVA AUSTRIA GMBH
Reel/Frame 034067/0290 →
Assignment of Assignor's Interest Oct 30, 2014
From: ELLINGSWORTH, LARRY R.; FLYER, DAVID; TIAN, JING-HUI; FUHRMANN, STEVEN R.
To: INTERCELL USA, INC.
Reel/Frame 034067/0261 →
Change of Name Aug 22, 2016
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 039498/0660 →
Change of Name Aug 22, 2016
From: VIVALIS SA
To: VALNEVA
Reel/Frame 039498/0958 →
Assignment of Assignor's Interest Aug 22, 2016
From: GUEHENNEUX, FABIENNE; MOREAU, KARINE; ESNAULT, MAGALI; MEHTALI, MAJID
To: VIVALIS SA
Reel/Frame 039498/0882 →
Asset Transfer Agreement Aug 22, 2016
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 039793/0001 →
Assignment of Assignor's Interest Aug 22, 2016
From: SCHLEGL, ROBERT; MOHLEN, MICHAEL; WRUSS, JURGEN; WEBER, MICHAEL
To: INTERCELL AG
Reel/Frame 039771/0993 →
Assignment of Assignor's Interest Aug 9, 2017
From: WESTRITSCHNIG, KERSTIN
To: VALNEVA AUSTRIA GMBH
Reel/Frame 043244/0283 →
Assignment of Assignor's Interest Aug 9, 2017
From: ELLINGSWORTH, LARRY R.; FLYER, DAVID; TIAN, JING-HUI; FUHRMANN, STEVEN R.
To: INTERCELL USA, INC.
Reel/Frame 043244/0297 →
Change of Name Jan 17, 2018
From: INTERCELL USA, INC.
To: VALNEVA USA, INC.
Reel/Frame 045080/0035 →
Change of Name Jan 17, 2018
From: INTERCELL USA, INC.
To: VALNEVA USA, INC.
Reel/Frame 045080/0170 →
Assignment of Assignor's Interest Feb 9, 2018
From: SCHLEGL, ROBERT; WEBER, MICHAEL
To: VALNEVA SE
Reel/Frame 044883/0626 →
Assignment of Assignor's Interest Aug 22, 2018
From: BARBERO CALZADO, JANA; NEBENFÜHR, MARIO; SCHLEGL, ROBERT; WEBER, MICHAEL
To: VALNEVA SE
Reel/Frame 046657/0659 →
Security Interest Mar 4, 2020
From: VALNEVA SE; VALNEVA USA, INC.; VALNEVA AUSTRIA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052016/0745 →
Assignment of Assignor's Interest Mar 13, 2020
From: ELLINGSWORTH, LARRY R.; FLYER, DAVID; TIAN, JING-HUI; FUHRMANN, STEVEN R.
To: INTERCELL USA, INC.
Reel/Frame 052110/0016 →
Assignment of Assignor's Interest Mar 13, 2020
From: WESTRITSCHNIG, KERSTIN
To: VALNEVA AUSTRIA GMBH
Reel/Frame 052109/0840 →
Change of Name Mar 13, 2020
From: INTERCELL USA, INC.
To: VALNEVA USA, INC.
Reel/Frame 052164/0750 →
Assignment of Assignor's Interest Mar 19, 2020
From: CALZADO, JANA BARBERO; NEBENFÜHR, MARIO; SCHLEGL, ROBERT; WEBER, MICHAEL
To: VALNEVA SE
Reel/Frame 052166/0314 →
Change of Name Mar 19, 2020
From: INTERCELL USA, INC.
To: VALNEVA USA, INC.
Reel/Frame 052190/0262 →
Security Interest Jun 24, 2020
From: VALNEVA SE; VALNEVA AUSTRIA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 053022/0939 →
Assignment of Assignor's Interest Dec 10, 2021
From: SCHLEGL, ROBERT; WEBER, MICHAEL
To: VALNEVA SE
Reel/Frame 058362/0397 →
Assignment of Assignor's Interest May 9, 2022
From: WESTRITSCHNIG, KERSTIN
To: VALNEVA AUSTRIA GMBH
Reel/Frame 059912/0047 →
Change of Name May 9, 2022
From: INTERCELL USA, INC.
To: VALNEVA USA, INC.
Reel/Frame 059912/0050 →
Assignment of Assignor's Interest May 9, 2022
From: ELLINGSWORTH, LARRY R.; FLYER, DAVID; TIAN, JING-HUI; FUHRMANN, STEVEN R.
To: INTERCELL USA, INC.
Reel/Frame 059866/0717 →
Assignment of Assignor's Interest Aug 25, 2022
From: WESTRITSCHNIG, KERSTIN
To: VALNEVA AUSTRIA GMBH
Reel/Frame 061315/0873 →